Carpio C, Bouabdallah R, Ysebaert L, et al. Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier. iBlood/i. 2020;135(13):996-1007.

0 avis

Carpio C, Bouabdallah R, Ysebaert L, et al. Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier. Blood. 2020;135(13):996-1007.

Archive ouverte

Edité par CCSD ; American Society of Hematology -

International audience. No abstract available

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Une collection unique de cellules viables humaines cryopréservées de patients atteints de lymphomes, une initiative pour accélérer l'innovation et son transfert dans le domaine du lymphome.

Archive ouverte | Mollaret, E | CCSD

International audience

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study

Archive ouverte | Lefrère, F | CCSD

International audience. Mantle cell lymphoma (MCL) is a distinct clinico-pathological entity with a poor prognosis. We have conducted a prospective study in patients with MCL to evaluate a therapeutic strategy in wh...

Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas

Archive ouverte | Ballester, B | CCSD

International audience. The classification of peripheral T-cell lymphomas (PTCL) is still a matter of debate. To establish a molecular classification of PTCL, we analysed 59 primary nodal T-cell lymphomas using cDNA...

Chargement des enrichissements...